propranolol has been researched along with Elevated ICP (Intracranial Pressure) in 2 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Excerpt | Relevance | Reference |
---|---|---|
"Pretreatment with propranolol prevents damage." | 5.31 | [Propranolol protects the myocardium and prevents arterial hypotension in an experimental organ donation model]. ( Cerro Sánchez, J; Domínguez Roldán, JM; Hernández Fernández, A; Ojeda Rivero, R; Ordóñez Fernández, A, 2002) |
"Pretreatment with propranolol prevents damage." | 1.31 | [Propranolol protects the myocardium and prevents arterial hypotension in an experimental organ donation model]. ( Cerro Sánchez, J; Domínguez Roldán, JM; Hernández Fernández, A; Ojeda Rivero, R; Ordóñez Fernández, A, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ojeda Rivero, R | 1 |
Cerro Sánchez, J | 1 |
Ordóñez Fernández, A | 1 |
Domínguez Roldán, JM | 1 |
Hernández Fernández, A | 1 |
Ojeda-Rivero, R | 1 |
Hernández-Fernández, A | 1 |
Dominguez-Roldán, JM | 1 |
Calderón, E | 1 |
Ruiz, M | 1 |
Lage, E | 1 |
Ordoñez-Fernandez, A | 1 |
2 other studies available for propranolol and Elevated ICP (Intracranial Pressure)
Article | Year |
---|---|
[Propranolol protects the myocardium and prevents arterial hypotension in an experimental organ donation model].
Topics: Adrenergic beta-Antagonists; Animals; Biomarkers; Brain Death; Catecholamines; Catheterization; Cran | 2002 |
Experimental treatment with beta blockers of hemodynamic and myocardial changes in organ donors.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain Death; Epinephrine; Heart; Heart Rate; H | 2002 |